The three most consequential genome editing technologies differ on one fundamental axis: how they treat the DNA strand. CRISPR-Cas9 cuts both strands and lets the cell's repair machinery finish the job. Base editing chemically converts one DNA letter to another without cutting the strand. Prime editing uses a "search-and-replace" mechanism, described by its developers as writing new genetic information in place. All three have therapeutic ambitions, but each suits a different class of mutation and a different tolerance for risk.
Introduction to Gene Editing Technologies
Since the discovery of the CRISPR-Cas system, molecular biology has moved from a single blunt instrument to a family of increasingly refined editors. The technologies described here are CRISPR-Cas9, base editing, and prime editing, and the useful way to distinguish them is along three questions. Does the tool cut DNA, and if so, how? What kinds of genetic changes can it make? And does it require the cell to supply additional material, such as a donor DNA template, to complete the edit?
As Biotech Primer explains in its comparison of the three technologies, researchers choose between these tools based on the mutation type they need to correct and the precision each application requires. That single sentence captures the practical logic of the whole field: the right editor is the one whose mechanism matches the genetic error at hand, not simply the newest one.
CRISPR-Cas9: The Foundational 'Cut and Paste' Method
CRISPR-Cas9 is the original workhorse, and its mechanism is defined by the double-strand break. The Cas9 enzyme is guided to a chosen genomic location and cuts both strands of the DNA. From that moment, the outcome depends on the cell's own repair pathways, which are imperfect. Repairs made by these pathways can be error-prone, and that imprecision is the technology's central limitation.
The types of edits possible follow directly from this cut-and-repair logic. According to Biotech Primer, CRISPR-Cas9 is primarily used for gene knockouts and small insertions or deletions, known as indels. If a researcher wants a precise insertion or correction rather than a disruption, a donor DNA template is required so the cell can copy the intended sequence during repair. For simple knockouts, no donor is needed. This makes CRISPR-Cas9 powerful for inactivating genes but comparatively clumsy for precisely rewriting them.
Base Editing: Precise 'Chemical Conversion' Without Double-Strand Breaks
Base editing was developed to sidestep the double-strand break entirely. David Liu's laboratory at the Broad Institute engineered two classes of base editors, CBEs and ABEs, described by the Simons Center at MIT as enabling all four types of transition mutations—C to T, T to C, A to G, and G to A—to be efficiently installed or corrected at target positions without making double-strand breaks, donor DNA templates, or reliance on the repair pathway called HDR.
The editor chemically converts one DNA nucleotide to another, directly modifying the target base. Because it never cleaves the chromosome, it minimizes the undesired consequences of chromosomal cleavage, as Front Line Genomics notes in its explainer on base and prime editing. This makes it a valuable tool for correcting the point mutations associated with genetic diseases. The trade-off is scope: base editing's biggest limitation, as the same explainer observes, is that very few types of point mutation can be changed with CBEs or ABEs. Insertions, deletions, and transversions remain out of reach.





